Upcoming Events
Log In
Pricing
Free Trial

Audience Questions

HIDE
PrevNext

0:00

And so that's my seven cases that I have for the group.

0:03

There is a Q & A question.

0:07

Yes.

0:07

So in my experience, how often do you see calcification in SPEN?

0:09

How often do you see mets from a SPEN?

0:13

I don't see calcifications very often.

0:15

And in the cases of SPEN that I have seen,

0:19

I have not seen a case of a metastasis.

0:22

Now, I've only seen maybe

0:25

eight cases of SPEN that I can remember,

0:27

eight to ten cases, and I have it...

0:31

you know that

0:31

the malignancy potential is up to about less than 20%.

0:35

And that's across all cases of SPEN in the literature.

0:38

So it's not something that we see very often,

0:40

but we do follow a patient who had SPEN to make sure we don't see it.

0:43

But I haven't seen it very often at all.

0:47

How common is percutaneous pancreatic biopsy in your practice?

0:51

It's not common at all.

0:53

In fact, I can't think of

0:56

any cases in the past that we've actually done it percutaneously.

1:00

It's almost always done via endoscopic ultrasound

1:04

in order to gain access to the pancreas.

1:09

Perhaps if it's a peripancreatic nodule that endoscopic ultrasound may be

1:13

difficult to access because of vessels in the region that you could obtain,

1:16

you could consider a percutaneous approach

1:17

but we certainly don't do a lot of those here.

1:20

In fact, I don't think I've seen any that I can recall of late.

1:23

That's a good question. Thank you everybody.

1:27

Bye.

Report

Faculty

Mahan Mathur, MD

Associate Professor, Division of Body Imaging; Vice Chair of Education, Dept of Radiology and Biomedical Imaging

Yale School of Medicine

Tags

Pancreas

Oncologic Imaging

MRI

Gastrointestinal (GI)

CT

Body

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy